ArticleEmerging microbes & infections2020
Identification of novel tetracycline resistance gene
Article in Emerging microbes & infections, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 67 citations in OpenAlex.
- Evolution, Mechanisms, and Therapeutic Implications of Mobile Tetracycline Destructases.BioEssays : news and reviews in molecular, cellular and developmental biology · 2026Review
- Emergence of tet(X6) and blaBMC microbiology · 2026Article
- Genotypic and Phenotypic Characterization ofMicroorganisms · 2026Article
- Emergence of the mobile RND-type efflux pump gene cluster tmexCD1-toprJ1 in Klebsiella pneumoniae clinical isolates in Japan.The Journal of antimicrobial chemotherapy · 2025Article
- The emergence and spread ofFrontiers in cellular and infection microbiology · 2025Article
- Characterization of antimicrobial resistantCurrent research in food science · 2025Article
- Concurrence of Inactivation Enzyme-Encoding GenesFoods (Basel, Switzerland) · 2024Article
- Coexistence of plasmid-mediatedMicrobiology spectrum · 2024Article
- Sequence-structure-function characterization of the emerging tetracycline destructase family of antibiotic resistance enzymes.Communications biology · 2024Article
- The tigecycline resistance mechanisms in Gram-negative bacilli.Frontiers in cellular and infection microbiology · 2024Review
- Characteristics ofAntibiotics (Basel, Switzerland) · 2023Article
- IncHI1 plasmids mediated theFrontiers in microbiology · 2023Article
- Identification of NovelMicrobiology spectrum · 2022Article
- Widespread Dissemination of Plasmid-Mediated Tigecycline Resistance GeneMicrobiology spectrum · 2022Article
- Fecal Carriage ofAntibiotics (Basel, Switzerland) · 2022Article
- Functional and phylogenetic analysis of TetX variants to design a new classification system.Communications biology · 2022Article
- Mobilization ofAntimicrobial agents and chemotherapy · 2022Article
- Dissemination and prevalence of plasmid-mediated high-level tigecycline resistance geneFrontiers in microbiology · 2022Review
- Source Tracking and Global Distribution of the Tigecycline Non-SusceptibleMicrobiology spectrum · 2021Article
- Emerging Opportunity and Destiny ofMicrobiology spectrum · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tigecycline is one of the last-resort antibiotics to treat severe infections. Recently, tigecycline resistance has sporadically emerged with an increasing trend, and Tet(X) family represents a new resistance mechanism of tigecycline. In this study, a novel chromosome-encoded tigecycline resistance gene,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.